Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Xeroderma Pigmentosum, Type G-Cockayne Syndrome

Known as: XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME, XPG/CS, Xpg-Cs 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
It is evident that gene-gene interactions are pervasive in the determination of the susceptibility of human diseases… Expand
2019
2019
BACKGROUND The xeroderma pigmentosum group G (XPG) gene at chromosome 13q33 consists of 15 exons, which may be related to the… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2014
2014
The mechanisms driving the inverse association between recreational physical activity (RPA) and breast cancer risk are complex… Expand
2012
2012
Despite of the importance of epigenetic regulation in neurological disorders, little is known about neuronal chromatin… Expand
  • figure 1
  • figure 2
Highly Cited
2009
Highly Cited
2009
Platinum-based chemotherapeutics is the most common regimens for advanced NSCLC patients. However, it is difficult to identify… Expand
  • table 1
  • table 2
  • table 4
  • table 5
2009
2009
DNA repair capacity (DRC) is correlated with sensitivity of cancer cells toward platinum-based chemotherapy. We hypothesize that… Expand